Please login to the form below

Not currently logged in
Email:
Password:

BMS appoints Peter Arduini to board of directors

He brings experience from Integra LifeSciences and Baxter Healthcare

BMS Peter ArduiniBristol-Myers Squibb has appointed Peter Arduini to its board of directors, effective 1 April.

Arduini brings over 25 years of medical technologies expertise to the biopharmaceutical company's board and currently serves as president, chief executive officer and director of Integra LifeSciences, a US-based medical technology company.

Prior to joining Integra LifeSciences, Arduini held the roles of corporate vice president and president of medication delivery at Baxter Healthcare from 2005 until 2010, overseeing its inpatient acute care in hospital markets portfolio.

Lamberto Andreotti, chairman of BMS, said: “Pete is a confident and engaging leader who has delivered tremendous results throughout his career.

“His commercial, financial and operational experience, along with a deep understanding of healthcare, make him an ideal choice for our board.”

Arduini will also become a member of BMS' audit committee of the board of directors on 3 May.

17th March 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics